Nuvation Bio (NUVB)Duquesne Family Office opened a new position $19.5M

4.54M

Shares reported

0.58%

Disclosed portfolio weight

$19.5M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 4, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Jun 24, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
2. Jun 30, 2026Company filing · Form 8-K · New debt, Other newsTook on new debt or obligations, and reported other company news
3. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Nuvation Bio

OQRO holds no insider, Congress, fund or contract record for Nuvation Bio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NUVB page.

How this filing works

• SEC Form 13F

Other disclosures at Nuvation Bio

• SEC Form 13F-HRMay 14, 2026
• SEC Form 4Jun 18, 2025
• SEC Form 4Jun 18, 2025
• SEC Form 4Jun 18, 2025
• SEC Form 4Jun 18, 2025
• SEC Form 4May 6, 2025

Everything OQRO holds on this company is on its NUVB page.